2024 asa guidance glp-1 receptor agonists perioperative 🔴 RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before anesthesia if asymptomatic, with extended fasting to reduce aspiration risk Collection_Digestion Video: Non-insulin injectable antidiabetic Type:Paperback

2024 asa guidance glp-1 receptor agonists perioperative 🔴 RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before anesthesia if asymptomatic, with extended fasting to reduce aspiration risk Collection_Digestion Video: Non-insulin injectable antidiabetic Type:Paperback

Video: Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology | Osmosis

Dankner R, Murad H, Agay N, Olmer L, Freedman LS

Collection_Digestion

Type:Paperback

Visible weight loss typically becomes apparent after 2-3 months as you reach higher doses